Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C076996 |
27-hydroxycholesterol |
NPC1 protein affects the abundance of 27-hydroxycholesterol | affects abundance | 18483620
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of NPC1 mRNA | decreases expression | 18648102
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of NPC1 mRNA | affects expression | 17562736
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of NPC1 mRNA | increases expression | 18687144
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of NPC1 mRNA | decreases expression | 19131362
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of NPC1 protein | decreases expression | 19131362
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of NPC1 mRNA | decreases expression | 19131362
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NPC1 mRNA | decreases expression | 19150397
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of NPC1 mRNA | decreases expression | 20678512
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of NPC1 mRNA | increases expression | 15336504
|
D002211 |
Capsaicin |
Capsaicin results in increased expression of NPC1 mRNA | increases expression | 18533110
|
D002784 |
Cholesterol |
NPC1 protein affects the abundance of Cholesterol | affects abundance | 18483620
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of NPC1 mRNA | increases expression | 20106945
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of NPC1 mRNA | decreases expression | 18042831
|
C098720 |
fingolimod |
fingolimod results in increased expression of NPC1 protein | increases expression | 20056921
|
C098720 |
fingolimod |
NPC1 protein affects the reaction [fingolimod results in increased expression of ABCA1 protein] | affects reaction|increases expression | 20056921
|
C027185 |
indirubin |
indirubin results in increased expression of NPC1 mRNA | increases expression | 15056799
|
C041786 |
palm oil |
palm oil results in decreased expression of NPC1 mRNA | decreases expression | 18042831
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NPC1 mRNA | affects binding|increases activity|increases expression | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of NPC1 mRNA | decreases expression | 18445702
|
C059514 |
resveratrol |
resveratrol results in increased expression of NPC1 mRNA | increases expression | 19371625
|
D013467 |
Sulindac |
Sulindac results in increased expression of NPC1 mRNA | increases expression | 11906190
|
D013749 |
Tetrachlorodibenzodioxin |
AHR protein affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of NPC1 protein] | affects reaction|decreases expression | 19131362
|
D013749 |
Tetrachlorodibenzodioxin |
ARNT protein affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of NPC1 protein] | affects reaction|decreases expression | 19131362
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of NPC1 mRNA | decreases expression | 19131362
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of NPC1 protein | decreases expression | 19131362
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of NPC1 mRNA | increases expression | 15056799
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Sulindac |
5.44 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Capsaicin |
8.49 | 18926900 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.49 | 14514962 11752688 15322242 |
MESH:D058186 |
Acute Kidney Injury |
|
Capsaicin |
14.30 | 18460982 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
14.30 | 16538975 |
MESH:D058186 |
Acute Kidney Injury |
|
Sulindac |
14.30 | 7897758 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.05 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.60 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Sulindac |
4.60 | 11910360 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
15.71 | 3712494 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
15.71 | 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
15.71 | 15688382 |
MESH:D000236 |
Adenoma |
|
Sulindac |
15.71 | 10223192 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.70 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.70 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Sulindac |
4.54 | 16460482 11535846 19003578 11874996 15623613 17611924 12394442 |
MESH:D000505 |
Alopecia |
|
Capsaicin |
4.67 | 17569567 |
MESH:D000544 |
Alzheimer Disease |
|
27-hydroxycholesterol |
4.81 | 20157255 14523054 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
4.81 | 16162502 16183991 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.89 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.79 | 10982225 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.01 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.82 | 15238619 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
3.46 | 17115116 |
MESH:D050197 |
Atherosclerosis |
therapeutic |
|
| 18483620 |
MESH:D050197 |
Atherosclerosis |
|
27-hydroxycholesterol |
15.60 | 9059518 11166758 |
MESH:D050197 |
Atherosclerosis |
|
Cholesterol |
15.60 | 16632123 |
MESH:D050197 |
Atherosclerosis |
|
fingolimod |
15.60 | 20056921 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
15.60 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.42 | 18445737 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.96 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.56 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.56 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.73 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.72 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.80 | 11985600 |
MESH:D001913 |
Bowen's Disease |
|
Sulindac |
5.30 | 11207687 |
MESH:D001919 |
Bradycardia |
|
Capsaicin |
4.99 | 18207255 |
MESH:D002545 |
Brain Ischemia |
|
Capsaicin |
10.36 | 19211983 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
10.36 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.93 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.93 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.93 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.93 | 16393696 17651959 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Sulindac |
2.93 | 16642371 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.93 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.74 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
4.52 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.52 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
4.52 | 16227395 19321006 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.93 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.53 | 16675471 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.64 | 7296757 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.66 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
4.66 | 16227395 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.33 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.43 | 15458977 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.54 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
10.87 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
10.87 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
10.87 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.10 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
13.09 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
13.09 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
13.09 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.08 | 8697196 12621046 15668235 16354765 15340226 |
MESH:D003092 |
Colitis |
|
resveratrol |
4.06 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
4.12 | 16338953 |
MESH:D003110 |
Colonic Neoplasms |
|
Sulindac |
4.12 | 12458338 12902858 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.92 | 16550006 |
MESH:D015179 |
Colorectal Neoplasms |
|
Sulindac |
2.92 | 11197048 10666051 18059344 11076880 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.00 | 14669216 17141729 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.71 | 16507316 |
MESH:D003371 |
Cough |
|
Capsaicin |
5.12 | 10350223 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 15322242 10048152 20055451 |
MESH:D003715 |
Dengue |
|
27-hydroxycholesterol |
5.62 | 19427377 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.74 | 8970840 11906362 11298694 14531868 12868966 2524372 18759878 8156756 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.39 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.43 | 2952479 3621924 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.71 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.65 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
3.90 | 16286809 |
MESH:D003930 |
Diabetic Retinopathy |
|
Sulindac |
5.11 | 17621415 12861449 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
6.00 | 8291058 6482804 18289764 7440962 18648102 9653073 18692083 6679447 11289319 9022650 9328219 1440618 16192314 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.00 | 12540782 10915739 17562736 19085960 12594235 15968718 19420014 11739529 10663392 14986274 15619225 11461765 11421492 12705907 10774834 12958197 19923254 16109766 11529661 16781746 12153990 16081117 19370779 17906064 16485898 11834606 12392966 16227642 2444490 18071297 14550746 11743745 16393943 18713872 17522070 16177239 19164858 14725611 19739265 11287661 19416960 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.00 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.04 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.71 | 11462148 |
MESH:D004381 |
Duodenal Ulcer |
|
Capsaicin |
4.63 | 10671773 11535926 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.40 | 18367378 |
MESH:D004487 |
Edema |
|
pirinixic acid |
11.08 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
11.08 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
11.08 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.85 | 16714409 18230668 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
27-hydroxycholesterol |
9.64 | 17410599 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
9.64 | 17872969 |
MESH:D004715 |
Endometriosis |
|
Sulindac |
8.99 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.99 | 10568697 9294722 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.78 | 17923197 |
MESH:D004935 |
Esophageal Diseases |
|
Capsaicin |
5.64 | 19566590 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
10.28 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
10.28 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
10.28 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Sulindac |
10.28 | 12235107 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.96 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
12.70 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
12.70 | 19551842 19004024 17967931 18296743 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
12.70 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.39 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.96 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Sulindac |
5.42 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Sulindac |
5.07 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
14.35 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
14.35 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.35 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.62 | 16983495 |
MESH:D005764 |
Gastroesophageal Reflux |
|
Sulindac |
4.95 | 11910360 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.16 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Capsaicin |
4.07 | 18405923 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.97 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.54 | 10696789 |
MESH:D006356 |
Heartburn |
|
Capsaicin |
5.64 | 19566590 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.33 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.33 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.50 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.36 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.27 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.45 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.05 | 16221962 19176532 18467677 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.05 | 15340226 16120746 12621046 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.12 | 16876885 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.99 | 16959395 15340226 16354765 8697196 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.85 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Capsaicin |
7.85 | 17043245 17434803 |
MESH:D006937 |
Hypercholesterolemia |
|
27-hydroxycholesterol |
21.43 | 17873880 |
MESH:D006937 |
Hypercholesterolemia |
|
Cholesterol |
21.43 | 16933029 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
21.43 | 21332399 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
21.43 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.12 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
9.08 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
9.08 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.88 | 15034207 |
MESH:D006968 |
Hypersensitivity, Delayed |
|
indirubin |
5.88 | 11275354 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.86 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.86 | 18670907 18850075 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.24 | 17488730 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.58 | 17600658 |
MESH:D007249 |
Inflammation |
|
Capsaicin |
15.54 | 16956363 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
15.54 | 20412841 |
MESH:D007249 |
Inflammation |
|
resveratrol |
15.54 | 16366677 |
MESH:D007249 |
Inflammation |
|
Sulindac |
15.54 | 3291741 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
15.54 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.49 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
12.08 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
12.08 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
12.08 | 16306350 |
MESH:D007414 |
Intestinal Neoplasms |
|
Sulindac |
4.57 | 12584176 12628509 12351151 10223192 12663524 10213222 |
MESH:D007417 |
Intestinal Polyps |
|
Sulindac |
4.92 | 11245490 12394442 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.96 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.39 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.67 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.67 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.08 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.08 | 12371664 |
MESH:D007859 |
Learning Disorders |
|
Cholesterol |
5.03 | 17134702 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.53 | 16087638 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.84 | 18296743 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
8.37 | 9327722 15034207 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
Sulindac |
8.37 | 12468960 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.11 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.11 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
6.66 | 12969438 11587558 16610002 16611625 19460945 12587719 19784758 19014921 |
MESH:D008107 |
Liver Diseases |
|
Capsaicin |
6.66 | 16956363 |
MESH:D008107 |
Liver Diseases |
|
Sulindac |
6.66 | 16867024 14986274 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.18 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
10.48 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
10.48 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
10.48 | 19321006 19073162 19812893 20405173 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.48 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
5.59 | 6587162 598648 3712494 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.59 | 12151625 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
3.96 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.43 | 6695378 20064080 18816296 18520028 18569708 20869020 20464547 17053015 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Sulindac |
3.43 | 19359593 15713900 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.43 | 19555203 11884234 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.24 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.81 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.19 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
3.07 | 11606380 8985016 |
MESH:D008545 |
Melanoma |
|
resveratrol |
3.75 | 17992120 |
MESH:D008545 |
Melanoma |
|
Sulindac |
3.75 | 16642371 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.50 | 19513568 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.16 | 18303189 16166281 16966607 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.31 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.73 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.14 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
Capsaicin |
7.65 | 17505005 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
7.65 | 16490592 16267019 17049120 17164350 14749477 17935668 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.81 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.44 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.65 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
5.65 | 16525036 16317513 16456233 17125593 17015251 17188708 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.83 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.83 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.89 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.70 | 17322642 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.44 | 3581430 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.71 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.71 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
3.94 | 8985016 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.39 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.23 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
9.37 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.37 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
2.87 | 6679447 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
13.86 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
13.86 | 17652729 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Sulindac |
13.86 | 16850258 17266991 |
MESH:D020078 |
Neurogenic Inflammation |
|
Capsaicin |
10.75 | 17961222 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
10.75 | 17929310 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
marker/mechanism |
|
| 9802331 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Cholesterol |
5.64 | 20557099 9802331 |
MESH:D009765 |
Obesity |
marker/mechanism |
|
| 19151714 |
MESH:D009765 |
Obesity |
|
Capsaicin |
7.43 | 19056576 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
7.43 | 20518802 21332399 18457598 17217161 18674790 11836018 20132043 16723640 19632207 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
7.43 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.36 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.96 | 3988306 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.19 | 17513867 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.93 | 11985600 |
MESH:D010146 |
Pain |
|
Acetaminophen |
11.14 | 16870215 |
MESH:D010146 |
Pain |
|
Capsaicin |
11.14 | 17043245 18987195 17084039 19081190 17434803 16996476 |
MESH:D010146 |
Pain |
|
Sulindac |
11.14 | 3291741 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Sulindac |
3.33 | 11504793 16820089 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.42 | 7296757 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.19 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.41 | 6228378 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.83 | 10923243 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.49 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.16 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
15.94 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
15.94 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
15.94 | 11118676 11399792 11896295 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.14 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.63 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.63 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.63 | 17675339 17718901 17636462 16731767 17804756 15767336 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.21 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.72 | 10548101 |
MESH:D011649 |
Pulmonary Alveolar Proteinosis |
|
27-hydroxycholesterol |
6.34 | 15466366 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
3.00 | 17365031 15814490 17322281 17975199 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.53 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
Capsaicin |
10.88 | 18460982 19211983 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
10.88 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
10.88 | 15827377 16317513 16314181 17058453 17520802 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.77 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.32 | 3692021 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
13.31 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
13.31 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
13.31 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.31 | 16192470 |
MESH:D019082 |
Smith-Lemli-Opitz Syndrome |
|
27-hydroxycholesterol |
5.96 | 11254748 |
OMIM:270800 |
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE |
|
27-hydroxycholesterol |
6.31 | 19812052 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.42 | 16321402 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.92 | 16684133 16045194 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
Capsaicin |
5.67 | 17997062 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.85 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.83 | 7505956 6582329 1399818 6587162 3712494 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
4.15 | 16227395 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.88 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
4.88 | 17053015 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.91 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
4.04 | 17473185 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.95 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
9.76 | 17044934 |
MESH:D014594 |
Uterine Neoplasms |
|
Sulindac |
9.76 | 18645019 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.93 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.54 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.24 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.19 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.68 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.39 | 17120751 |